Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

December 2015

Lab Stakeholders Take Action to Prevent Drastic Cuts in the Medicare Lab Fee Schedule

TDR Insider / By Mary Van Doren

WITH MANY CLINICAL LABORATORY STAKEHOLDERS anticipating major revenue shortfalls due to the Protecting Access to Medicare Act lab test market price reporting rule that went into effect January 1, THE DARK REPORT reports overlooked news that, at the behest of clinical laboratory associations, elected officials in Congress have signed a letter that asks the Centers for Medicare & Medicaid Services to …

Lab Stakeholders Take Action to Prevent Drastic Cuts in the Medicare Lab Fee Schedule Read More »

To access this post, you must purchase The Dark Report.

Official Makes Case in Favor of FDA LDT Guidance

TDR Insider / By Mary Van Doren

IN THIS EXCLUSIVE NEWS COVERAGE of a public appearance by a key FDA official, THE DARK REPORT provides lab executives and pathologists with a more nuanced understanding about the thinking behind the proposed FDA LDT guidance. Among the interesting insights are that FDA officials will not be surprised if some labs file a lawsuit challenging …

Official Makes Case in Favor of FDA LDT Guidance Read More »

To access this post, you must purchase The Dark Report.

December 28, 2015 Intelligence: Late Breaking Lab News

Late Breaking Lab News / By Robert Michel

To advance the practice of precision medicine through better use of genetic testing, a new limited liability corporation (LLC) was formed. Participating in the LLC are North Shore-LIJ Health System, the nation’s largest urban health system, OPKO Health, Inc., a pharmaceutical company, and GeneDx, a division of Bio-Reference Laboratories (both lab businesses are owned by OPKO). …

December 28, 2015 Intelligence: Late Breaking Lab News Read More »

To access this post, you must purchase The Dark Report.

FDA Official Makes Case In Favor of LDT Guidance

Laboratory Compliance / By Joseph Burns

CEO SUMMARY: Forty years ago, pathologists in hospital and academic labs worked closely with treating physicians to produce laboratory-developed tests for discrete clinical cases. Seeing that, the FDA decided not to regulate those tests, an FDA official said. Over time, however, use of LDTs became a serious concern when labs developing LDTs were no longer involved …

FDA Official Makes Case In Favor of LDT Guidance Read More »

To access this post, you must purchase The Dark Report.

Letter from Congress to CMS Asks for Delay in PAMA Reporting

Laboratory Compliance / By Joseph Burns

CLINICAL LABORATORY ASSOCIATIONS are using a letter-writing campaign to members of Congress as a last-minute Hail Mary attempt to head off the controversial lab price market reporting rule that CMS intends to implement after January 1. Both Democrats and Republicans in the U.S. House of Representatives and the U.S. Senate have signed a letter to …

Letter from Congress to CMS Asks for Delay in PAMA Reporting Read More »

To access this post, you must purchase The Dark Report.

Labs Can Earn Revenue through Data Analytics

Clinical Laboratory Trends / By Joseph Burns

CEO SUMMARY: There is a new buyer for lab test data, creating an opportunity for labs to build a new revenue stream. Medivo, Inc., of New York, describes itself as a healthcare data analytics company whose mission is to unlock the power of lab data to improve health. It works with clinical labs and pathology …

Labs Can Earn Revenue through Data Analytics Read More »

To access this post, you must purchase The Dark Report.

2015’s Top 10 Lab Stories Show Significant Changes

Clinical Laboratory Trends / By Robert Michel

CEO SUMMARY: During 2015, two stories captured the full attention of most pathologists and clinical lab managers. One was how CMS intends to gather lab price market data as mandated by PAMA. The other was the continued efforts by the FDA to move ahead on proposed guidance for regulation of LDTs. However, the full list …

2015’s Top 10 Lab Stories Show Significant Changes Read More »

To access this post, you must purchase The Dark Report.

Lab Industry’s Non-Stories for 2015

Commentary and Opinion by R. Lewis Dark / By R. Lewis Dark

AT THE END OF EACH YEAR, IT IS GENERALLY EASY TO PICK OUT the stories of greatest significance for the lab industry during the previous 12 months. But what is often overlooked are the non-stories. These are the events that did not happen in the year, despite earlier occurrences and the momentum pushing certain trends …

Lab Industry’s Non-Stories for 2015 Read More »

To access this post, you must purchase The Dark Report.

Cleveland Clinic and related lab sue True Health Diagnostics

TDR Insider / By Mary Van Doren

THE DARK REPORT is the only lab industry news source to recognize the significance of the lawsuit between the Cleveland Clinic Foundation and Cleveland HeartLab against a new lab company, True Health Diagnostics. It is the latest chapter in a string of questionable sales practices engaged in by defendants in the federal whistleblower lawsuit against Health …

Cleveland Clinic and related lab sue True Health Diagnostics Read More »

To access this post, you must purchase The Dark Report.

TriCore Reference Labs Adds Value With Consults, Better TAT – June 17, 2013

The Dark Report / By R. Lewis Dark

CEO SUMMARY: Motivated by the goal of delivering more value to clinicians and client hospitals, the lab team at TriCore Reference Laboratories in Albuquerque, New Mexico, is proactively introducing new services. One such initiative is to travel to hospitals to participate in rounds and consult with physicians regularly. Another initiative improved the accuracy of C. …

TriCore Reference Labs Adds Value With Consults, Better TAT – June 17, 2013 Read More »

To access this post, you must purchase The Dark Report.

;